Induced pluripotent stem cell-derived models for mtDNA diseases.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Methods in Enzymology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-12-801415-8.00019-9PMID 25416367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application

  2014cited by this paper
• Generation of insulin-producing β-like cells from human iPS cells in a defined and completely xeno-free culture system.

  2014cited by this paper
• Human Stem Cells for Modeling Heart Disease and for Drug Discovery

  2014cited by this paper
• Disease‐Causing Mitochondrial Heteroplasmy Segregated Within Induced Pluripotent Stem Cell Clones Derived from a Patient with MELAS

  2013influential reference
• Tissue- and cell-type–specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model

  2013influential reference
• Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.

  2013cited by this paper
• Induced Pluripotent Stem Cells with a Mitochondrial DNA Deletion

  2013influential reference
• Efficient generation of human iPSCs by a synthetic self-replicative RNA.

  2013cited by this paper
• Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics

  2013cited by this paper
• An Efficient Nonviral Method to Generate Integration‐Free Human‐Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells

  2013influential reference
• RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.

  2013cited by this paper
• Disease-specific iPS cell models in neuroscience.

  2013cited by this paper
• Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation

  2012cited by this paper
• Mitochondria: In Sickness and in Health

  2012cited by this paper
• Rapid mitochondrial DNA segregation in primate preimplantation embryos precedes somatic and germline bottleneck.

  2012cited by this paper
• Generation of human induced pluripotent stem cells from urine samples

  2012cited by this paper
• Generation of Retinal Pigment Epithelial Cells from Small Molecules and OCT4 Reprogrammed Human Induced Pluripotent Stem Cells

  2012cited by this paper
• Mouse mtDNA mutant model of Leber hereditary optic neuropathy

  2012cited by this paper
• Mechanisms of mitochondrial diseases

  2012influential reference
• Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors

  2011cited by this paper
• Transmitochondrial mice as models for mitochondrial DNA-based diseases.

  2011cited by this paper
• In brief

  2011cited by this paper
• A more efficient method to generate integration-free human iPS cells

  2011cited by this paper
• Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture

  2011cited by this paper
• The Use of Induced Pluripotent Stem Cells in Drug Development

  2011cited by this paper
• Generation of Retinal Pigment Epithelial Cells from Human Induced Pluripotent Stem Cells

  2010cited by this paper
• Semiquantitative histopathology and 3D magnetic resonance microscopy as collaborative platforms for tissue identification and comparison within teratomas derived from pedigreed primate embryonic stem cells.

  2010cited by this paper
• Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

  2010cited by this paper
• Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells

  2010cited by this paper
• Reprogramming of human peripheral blood cells to induced pluripotent stem cells.

  2010cited by this paper
• Generation of functional human hepatic endoderm from human induced pluripotent stem cells

  2009cited by this paper
• Supplemental Data Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins

  2009cited by this paper
• Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.

  2009cited by this paper
• Disease-specific induced pluripotent stem cells.

  2008cited by this paper
• Pathogenic Mitochondrial DNA Mutations Are Common in the General Population

  2008cited by this paper
• Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

  2008cited by this paper
• Strong Purifying Selection in Transmission of Mammalian Mitochondrial DNA

  2008cited by this paper
• The mitochondrial bottleneck occurs without reduction of mtDNA content in female mouse germ cells

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007influential reference
• Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike Episodes (MELAS)

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006influential reference
• Clinical features of A3243G mitochondrial tRNA mutation.

  2004cited by this paper
• Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation

  2004cited by this paper
• Minimum birth prevalence of mitochondrial respiratory chain disorders in children.

  2003cited by this paper
• [Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes].

  2001cited by this paper
• Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes

  2000cited by this paper
• Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness

  1992cited by this paper
• Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke‐like episodes (MELAS)

  1992cited by this paper
• MELAS: Clinical features, biochemistry, and molecular genetics

  1992cited by this paper
• A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies

  1990cited by this paper
• Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation.

  1989cited by this paper
• A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction.

  1979cited by this paper

• MitImpact 3: modeling the residue interaction network of the Respiratory Chain subunits

  2020cites this paper
• Disease modeling of bone marrow failure syndromes using iPSC-derived hematopoietic stem progenitor cells.

  2019cites this paper
• Pathophysiological characterization of MERRF patient-specific induced neurons generated by direct reprogramming.

  2019cites this paper
• Potential applications of induced pluripotent stem cells (iPSCs) in the modeling of gastrointestinal disorders.

  2015cites this paper
• Challenges to understand the mitochondrial respiratory diseases caused by mitochondrial DNA mutations.

  2015cites this paper